News Headline Summary

Wellpoint approves Sequenom's (SQNM) MaterniT21 test for DNA prenatal screening calling it medically necessary

Reaction details:

- Co. shares move 3.19% higher in immediate reaction to the news from USD 4.70 to USD 4.85.

Print 14:48, 19 Dec 2012 - US Equities - Source: B4THESTREET.COM